APA
None, H., None, M., None, K., None, W., None, K. & None, J. (2024). KRAS Mutation Incidence in Metastatic Colorectal Cancer and Response to Cetuximab : Preliminary Results in the Lebanese Population. Lebanese Medical Journal, 58(1), None-None.
MLA
None, Habre, et al. "KRAS Mutation Incidence in Metastatic Colorectal Cancer and Response to Cetuximab : Preliminary Results in the Lebanese Population." Lebanese Medical Journal 58.1 (2024): None-None.
Chicago
None, Habre, M. , Karam , W. , Kattan and J. . "KRAS Mutation Incidence in Metastatic Colorectal Cancer and Response to Cetuximab : Preliminary Results in the Lebanese Population." Lebanese Medical Journal 58, no. 1 (2024): None-None.
Harvard
None, H., None, M., None, K., None, W., None, K. and None, J. (2024) 'KRAS Mutation Incidence in Metastatic Colorectal Cancer and Response to Cetuximab : Preliminary Results in the Lebanese Population' Lebanese Medical Journal 58(1), pp. None-None.
Vancouver
Habre H, M. M, Karam K, W. W, Kattan K, J. J. KRAS Mutation Incidence in Metastatic Colorectal Cancer and Response to Cetuximab : Preliminary Results in the Lebanese Population. Lebanese Medical Journal. 2024 ;58(1):None-None.
Download PDF
Download XML
